The Epidemiology of Sarcopenia

https://doi.org/10.1016/j.cger.2011.03.004Get rights and content

Section snippets

Prevalence of sarcopenia

The prevalence of sarcopenia observed in different research studies varies considerably. This reflects differences in the older population groups studied, the different techniques used to measure skeletal muscle mass and size, and differences in the normative (young and healthy) population groups that were used to derive the sarcopenia thresholds. Within the existing literature, the prevalence of sarcopenia in 60- to 70-year olds is in the order of 5% to 13%.16 These prevalence estimates

Influence of sarcopenia on physical function

Most research on the health implications of sarcopenia that were published before 2005 focused on physical function outcomes, such as difficulty performing activity of daily living and instrumental activities of daily living.6 The results from a few of the many cross-sectional studies are referred to in this paragraph to highlight the relationships that were reported. Using a cutoff for height-adjusted appendicular muscle mass of 2 standard deviations or more below the mean of young adults to

Influence of sarcopenia on metabolic function, chronic disease, and mortality

Several recent studies have considered the effect of a low muscle mass on metabolic function, chronic disease, and mortality. One of the metabolic effects of a loss in muscle mass is a modest decrease in resting metabolic rate consequent to the loss in skeletal muscle mass.18 Although it has been postulated that sarcopenia contributes to metabolic and cardiovascular diseases, such as insulin resistance, type 2 diabetes, dyslipidemia, and hypertension,19 the literature is mixed and, in general,

Relevance of muscle strength

A primary rationale for studying the age-related loss in muscle mass is the belief that the loss in muscle mass is indicative of a loss of muscle strength and function. Thus, in the causal chain, sarcopenia was thought to cause a loss in muscle strength, which in turn would cause functional impairment and physical disability. In fact, although the initial 1989 definition of sarcopenia focused exclusively on the loss in muscle mass, over time the definition of sarcopenia evolved into one that

Consensus definition of sarcopenia

The sarcopenia research that has been conducted over the past 2 decades has not been well integrated into clinical practice. Part of this reflects the vast array of definitions, thresholds, and measures that different researchers have used to identify the condition. To address this issue, the European Working Group on Sarcopenia in Older People (EWGSOP) was developed in 2009 to develop a consensus definition of sarcopenia that could be used in both the research and clinical settings. The EWGSOP

Summary

Research conducted within the past 2 decades has taught us a considerable amount about the health consequences of the age-related loss in muscle mass and strength. Although there is a large body of epidemiologic evidence linking sarcopenia (particularly a low muscle strength) to a loss in physical function, cardiometabolic disease, and mortality, the assessment and management of sarcopenia are not a routine part of clinical practice. It is hoped that the development of a consensus and

First page preview

First page preview
Click to open first page preview

References (45)

  • R.N. Baumgartner et al.

    Epidemiology of sarcopenia among the elderly in New Mexico

    Am J Epidemiol

    (1998)
  • A.J. Cruz-Jentoft et al.

    Understanding sarcopenia as a geriatric syndrome

    Curr Opin Clin Nutr Metab Care

    (2010)
  • I. Janssen et al.

    Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability

    J Am Geriatr Soc

    (2002)
  • M.J. Delmonico et al.

    Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women

    J Am Geriatr Soc

    (2007)
  • A.B. Newman et al.

    Sarcopenia: alternative definitions and associations with lower extremity function

    J Am Geriatr Soc

    (2003)
  • B.H. Goodpaster et al.

    The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study

    J Gerontol A Biol Sci Med Sci

    (2006)
  • M. Visser et al.

    Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons

    J Gerontol A Biol Sci Med Sci

    (2005)
  • I. Janssen

    Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study

    J Am Geriatr Soc

    (2006)
  • I. Janssen et al.

    Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women

    Am J Epidemiol

    (2004)
  • World Health Organization

    Ageing and life course

  • E. Lammes et al.

    Resting metabolic rate in elderly nursing home patients with multiple diagnoses

    J Nutr Health Aging

    (2006)
  • M. Aubertin-Leheudre et al.

    Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women

    Obesity (Silver Spring)

    (2006)
  • Cited by (0)

    The author is supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation and a Tier 2 Canada Research Chair.

    Conflicts of Interest: The author has nothing to disclose.

    View full text